Home » Healthcare » Pharmaceuticals » Postmenopausal Osteoporosis Treatment Market

Postmenopausal Osteoporosis Treatment Market By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents, Non-pharmacological Therapies) By Administration Method (Oral Medications, Intravenous Medications, Subcutaneous Injections) By Drug Delivery Systems (Conventional Formulations, Long-Acting Formulations) By Patient Demographics (Postmenopausal Women, Elderly Population) By End Users (Hospitals, Clinics and Physician Offices, Home Healthcare) By Patient Risk Factors, High-Risk Patients, Patients with Fractures) By Market Trends (Emerging Therapies, Personalized Medicine, Focus on Bone Health) By Region -Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Price: $4999

Published: | Report ID: 30802 | Report Format : PDF

Market Insights

  • The global demand for postmenopausal osteoporosis treatment was valued at USD 9514.5 Million in 2022 and is expected to reach USD 14601.8 Million in 2030, growing at a CAGR of 5.5% between 2023 and 2030.
  • The bisphosphonates segment is the market leader by treatment type, accounting for more than 20% of total value in 2022, while the monoclonal antibodies are likely to grow rapidly in the projection period.
  • The oral medications administration method category is expected to expand rapidly in the forecast period, while the intravenous medications segment has the highest market share in 2022.
  • The postmenopausal women patient demographics dominate the global demands for postmenopausal osteoporosis treatment, accounting for more than 55% in 2022.
  • The patients with fractures category is expected to expand the fastest throughout the forecast timeline, while the high-risk patients segment had a market share of more than 58% in 2022.
  • With a substantial market share of over 40% in 2022 and projections of high CAGR growth, the hospital end users category will likely continue to lead the global need for postmenopausal osteoporosis treatment.
  • The conventional formulations category dominated the market with 60% of the total revenue share by drug delivery systems. In contrast, the long-acting formulations will expand fastest over the projected time frame.
  • North America is fueling the rapid growth of the postmenopausal osteoporosis treatment industry with over one-third share in 2022, while Asia Pacific and Europe collectively account for just under 54% share in 2022. Europe held over 20% market revenue share in 2022.
  • Postmenopausal osteoporosis is a common condition among women, and the global prevalence has been steadily increasing, primarily due to an aging population.
  • According to the World Health Organisation (WHO), the worldwide population of people aged 60 and more will grow from one billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050.
  • Ongoing clinical trials and the development of novel therapeutic approaches, including new drug targets and regenerative medicine, contribute to the evolving landscape of osteoporosis treatment.

Postmenopausal Osteoporosis Treatment Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

Osteoporosis is a bone disorder characterized by decreased bone density and an increased risk of fractures. Postmenopausal women are especially vulnerable to osteoporosis due to hormonal changes, specifically a decline in estrogen levels after menopause. The market encompasses various therapeutic interventions, medications, and healthcare strategies aimed at preventing, managing, and treating postmenopausal osteoporosis. Treatment options often focus on improving bone density, reducing fracture risk, and enhancing overall bone health in postmenopausal women. Pharmaceutical interventions commonly involve the use of medications such as selective estrogen receptor modulators (SERMs), bisphosphonates, hormone replacement therapy (HRT), and, more recently, monoclonal antibodies.

Market Overview

The global postmenopausal osteoporosis treatment market has witnessed rapid growth in recent years and is predicted to grow at a CAGR of 5.5% between 2023 and 2030. The market was valued at USD 9514.5 million in 2022 and is projected to reach USD 14601.8 million in 2030.

Osteoporosis is a skeletal condition that primarily affects postmenopausal women and worsens with age. As a result, the bone loses density, and the integrity of the interior spongy structure deteriorates until the bone can no longer tolerate external pressures and strains, at which point the bone fractures. Osteoporosis has grown to be a major global healthcare concern due to its strong correlation with costs, morbidity, and mortality. People with low bone calcium are more susceptible to this condition, accounting for around 20% of cases. The global prevalence of combined hip, forearm, and spine fractures is anticipated to be between 40% and 50%.

The rising prevalence of osteoporosis is encouraging market growth, as more patients will raise demand for the treatments. Moreover, there is a continuous rise in the demand for osteoporosis medications. As per the International Osteoporosis Foundation, osteoporosis causes about 8.9 million fractures per year, resulting in an osteoporotic fracture every 3 seconds, and it is expected to affect 200 million women globally. Cases of osteoporosis are most common among people aged 40, 41-60, and over 60. The >60-year-old age group saw the most patients, with an estimated 10,275 in the United States in 2021. In 2021, the treatment-eligible population of osteoporosis amounted to 9,511 cases in the United States. As a result, the senior population has a larger risk of contracting this condition, further boosting market growth.

Segmentation by Treatment Type

  • The monoclonal antibodies segment is expected to exhibit the fastest CAGR, owing to the continuous advancements in biopharmaceutical research and their potential for targeted and effective postmenopausal osteoporosis treatment.
  • Currently, the bisphosphonates segment commands a significant market share, accounting for over 20% in 2022. This established market presence can be attributed to the long-standing use and proven efficacy of bisphosphonates in managing osteoporosis.

Segmentation by Administration Method

  • The oral medications segment is anticipated to achieve the highest CAGR in the projected period, owing to the increasing preference for convenient and patient-friendly oral treatments.
  • The intravenous medications category currently leads the market share with over 38% in 2022, driven by the immediate and efficient delivery of medications through this administration route.

Segmentation by Drug Delivery Systems

  • Conventional formulations dominate the drug delivery systems category, meeting more than 60% of the global market demand for postmenopausal osteoporosis treatment in 2022. This dominance is rooted in the familiarity and established efficacy of conventional formulations.
  • The long-acting formulations segment is poised to achieve the highest CAGR over the upcoming years, owing to a growing demand for sustained-release treatments that enhance patient adherence.

Segmentation by Patient Demographics

  • The elderly patient population is expected to post the highest CAGR, attributed to the increased prevalence of osteoporosis in aging demographics.
  • Postmenopausal women currently lead the market share with over 55% in 2022, underscoring the significance of hormonal changes as a major risk factor for osteoporosis.

Segmentation by End Users

  • The clinics and physician offices segment is anticipated to register the highest market CAGR over the projection period, driven by the increasing trend towards outpatient care and the convenience offered by these healthcare settings.
  • Currently, the hospitals category is in the lead with a market share of nearly 40% in 2022, owing to the longstanding role of hospitals in providing comprehensive osteoporosis treatment.

Segmentation by Patient Risk Factors

  • Patients with fractures will witness the highest CAGR in the coming years, emphasizing the clinical focus on addressing the acute needs of individuals with existing fractures.
  • The high-risk patients category currently leads the global market share, holding over 58% in 2022, highlighting the importance of proactive treatment strategies for individuals at elevated risk.

Segmentation by Market Trends

  • Emerging postmenopausal osteoporosis therapies stand out as the leading global market trends, reflecting the industry’s commitment to developing innovative and more effective treatment options.
  • The rest of the postmenopausal osteoporosis treatment market demand comes from personalized medicines and a heightened focus on bone health, aligning with a broader trend toward patient-centric and preventive healthcare approaches.

Segmentation by Region

  • North America emerges as a notably profitable region for industry players, commanding over one-third of the market share in 2022. This dominance is attributed to robust healthcare infrastructure and high awareness levels.
  • Europe and Asia Pacific collectively contributed just under 54% of the share in 2022. Europe, with over 20% share, demonstrates a mature and robust market presence, while Asia Pacific showcases significant growth potential driven by improving healthcare access and awareness.
  • The rest of the world, including Latin America, the Middle East, and Africa, fulfills the remaining demand for postmenopausal osteoporosis treatment, each region presenting diverse dynamics and unique growth opportunities in this evolving market.

Postmenopausal Osteoporosis Treatment Market Research

Key factors driving the global postmenopausal osteoporosis treatment market’s expansion include a robust late-stage product pipeline, an increase in disease burden among postmenopausal women due to an aging population, and lifestyle changes such as sedentary behavior, heavy drinking, and unhealthful eating patterns.

North America held the largest postmenopausal osteoporosis treatment market share of 40% in 2022, owing to factors such as well-developed healthcare infrastructure, a substantial presence of several industry players, a higher rate of accurate diagnosis and effective treatment, high patient compliance, and an extensive patient population. The United States is the largest contributor in North America. The Centers for Disease Control & Prevention (CDC) stated in 2021 that 18.8% of women aged 50 and up in the United States had osteoporosis. Sedentary lifestyles and bad eating and drinking habits are further expected to increase the prevalence. According to the National Osteoporosis Foundation, reduced bone mass will impact 71 million Americans by 2030.

The Asia Pacific region is anticipated to experience the most rapid growth in the postmenopausal osteoporosis treatment industry over the projection period due to a combination of demographic shifts, increasing healthcare awareness, and rising healthcare infrastructure. With a large and aging population, particularly in countries like China and Japan, there is a heightened prevalence of postmenopausal osteoporosis. As awareness about bone health grows and healthcare access improves, the demand for effective treatments is expected to surge. Additionally, pharmaceutical companies are recognizing the potential of the Asia Pacific market and are strategically expanding their presence in the region.

Key Highlights of the Report

The global postmenopausal osteoporosis treatment market is segmented by treatment type, administration method, drug delivery systems, patient demographics, end users, patient risk factors, market trends, and region. Bisphosphonate treatment types currently dominate the global market share, owing to their established role and efficacy in managing osteoporosis. Among the administration methods, oral medications are anticipated to gain market prominence due to their convenience. In drug delivery systems, conventional formulations hold a substantial market demand attributed to their dominance in meeting the needs of postmenopausal osteoporosis treatment. Postmenopausal women lead the market revenue share in terms of patient demographics, owing to the significant impact of hormonal changes as a key risk factor. In terms of end users, clinics and physician offices are poised for the highest market CAGR, indicating a trend towards outpatient care and decentralized treatment settings.

The postmenopausal osteoporosis market is mainly driven by an increase in estrogen levels following menopause, which causes an imbalance between bone formation and bone resorption, resulting in a net loss of bone density. Moreover, the increased prevalence of various associated risk factors, such as genetic predisposition, insufficient calcium and vitamin D intake, lack of physical activity, long-term use of corticosteroids, excessive use of alcohol, and so on, contributes to market expansion. Furthermore, the widespread use of oral bisphosphonates, including alendronate and risedronate, to prevent bone resorption and lower the likelihood of fractures in patients is providing a positive outlook for the industry. However, the market faces challenges, including patient adherence to long-term treatment regimens, higher treatment costs, and regulatory complexities.

The North American region holds a significant share of the global postmenopausal osteoporosis treatment market, driven by robust healthcare infrastructure, high awareness levels, and a substantial aging population. The region benefits from advanced medical research, contributing to the development and adoption of innovative treatment options. On the other hand, Asia Pacific emerges as a region of substantial growth potential in the global postmenopausal osteoporosis treatment market. With a large and aging population, particularly in countries like China and Japan, the prevalence of postmenopausal osteoporosis is on the rise. Improving healthcare infrastructure, increasing awareness about bone health, and a growing emphasis on preventive care contribute to the evolving landscape of osteoporosis treatment in this region.

What Are The Main Drivers Of The Global Postmenopausal Osteoporosis Treatment Market?

The global postmenopausal osteoporosis treatment market growth is primarily driven by the increasing aging population, particularly among women, and the associated rise in the prevalence of osteoporosis. As women enter menopause, hormonal changes, specifically a decline in estrogen levels, contribute to a higher susceptibility to osteoporosis. The growing awareness of the importance of bone health, coupled with advancements in diagnostic technologies and therapeutic interventions, fuels the market demand for effective treatments. Pharmaceutical innovations, including the development of biopharmaceuticals and monoclonal antibodies, further drive market growth. Moreover, increased healthcare initiatives, government support, and a focus on patient education contribute to the overall expansion of the postmenopausal osteoporosis treatment industry.

What Are The Major Challenges Faced By The Global Postmenopausal Osteoporosis Treatment Market?

One of the primary market obstacles is the issue of patient adherence to long-term treatment regimens, as osteoporosis often requires continuous medication and lifestyle management. The market also faces challenges related to the higher cost of certain osteoporosis treatments, impacting accessibility and affordability for a broader population. Generic competition, particularly with the expiration of patents for established drugs, poses a threat to market share for pharmaceutical companies. Moreover, concerns about the safety and side effects of certain medications, coupled with the need for personalized treatment strategies, add market complexity to clinical management.

What Are The Growth Opportunities In The Global Postmenopausal Osteoporosis Treatment Market?

The development of novel biopharmaceuticals and targeted therapies, including monoclonal antibodies, opens market avenues for more effective and tailored treatment options. Expansion into emerging markets, where aging populations are on the rise, offers untapped growth potential for pharmaceutical companies. The integration of digital health solutions, telemedicine, and wearable technologies in osteoporosis management provides market opportunities for remote patient monitoring and personalized care. Besides, collaborations between pharmaceutical firms and patient advocacy groups, coupled with increased investment in regenerative medicine and innovative diagnostic technologies, contribute to the market’s growth trajectory. Emphasis on comprehensive osteoporosis management, including lifestyle interventions and patient education programs, also creates opportunities for holistic approaches to care.

Market Drivers

Several factors drive the global postmenopausal osteoporosis treatment market. The following are the key drivers of the global postmenopausal osteoporosis treatment market:

Aging Population and Menopausal Demographics

One of the major drivers of the global postmenopausal osteoporosis treatment market growth is the demographic shift towards an aging population, particularly among women. As individuals age, the risk of developing osteoporosis increases, and postmenopausal women are particularly vulnerable due to hormonal changes, specifically a decline in estrogen levels. Estrogen plays a main role in maintaining bone density, and its reduction during menopause contributes to the onset of osteoporosis.

Osteoporosis affects around 1 in 10 women over the age of 60 worldwide and can cause up to 20% bone loss during these stages, as per recent studies. According to the International Menopause Society (IMS), more than 200 million women are predicted to have osteoporosis by 2021, with one in every three women over the age of 50 experiencing an osteoporosis fracture. The global increase in life expectancy and the proportion of postmenopausal women in the population create a substantial patient pool for osteoporosis treatment. The continuous growth of the aging population worldwide, especially in developed regions, underscores the sustained demand for effective postmenopausal osteoporosis treatments.

Market Restraints

The global postmenopausal osteoporosis treatment market faces challenges that may hinder its growth. These include the following:

High Initial Investment Costs

The high cost of certain osteoporosis treatments poses a key restraint on the postmenopausal osteoporosis treatment market expansion. Some of the advanced and effective drugs, including biopharmaceuticals and monoclonal antibodies, can be expensive, limiting accessibility for a broader patient population. Affordability issues may result in delayed or inadequate treatment, particularly in regions with limited healthcare resources or without comprehensive insurance coverage. The cost factor can also impact the decision-making process for healthcare providers and patients, leading to a preference for more cost-effective alternatives or generic medications.

Opportunities

The global postmenopausal osteoporosis treatment market offers significant growth opportunities. These include the following:

Integration of Digital Health Solutions and Personalized Medicine

The integration of digital health solutions and personalized medicine presents a major opportunity in the postmenopausal osteoporosis treatment market developments. Advancements in technology, including telehealth, wearable devices, and health apps, offer avenues for remote monitoring, real-time data collection, and enhanced patient engagement.

Digital solutions play a leading role in improving treatment adherence, providing lifestyle recommendations, and facilitating personalized care plans. Furthermore, the exploration of personalized medicine approaches, considering genetic and molecular factors, allows for tailored treatment strategies based on individual patient characteristics. This not only improves treatment efficacy but also aligns with a broader trend toward patient-centered healthcare.

Competitive Landscape

Postmenopausal Osteoporosis Treatment Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The competitive landscape of the global postmenopausal osteoporosis treatment market is characterized by intense competition among pharmaceutical and biotech companies aiming to address the growing healthcare needs of postmenopausal women. The following are some of the top market players and their market shares:

  • Amgen Inc
  • Eli Lilly & Company
  • Novartis International AG
  • Gilead Sciences Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co. Inc
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V. (now part of Viatris Inc)
  • Accord Healthcare Ltd
  • Others

These key market players actively focus on research and development operations, strategic collaborations, and product innovations to gain a competitive edge. The market is witnessing a dynamic interplay of established pharmaceutical giants and emerging biotech firms, each vying to offer effective and convenient treatment options. Factors such as the introduction of novel therapeutic approaches, advancements in biopharmaceuticals, and the exploration of regenerative medicine contribute to the market competitive dynamics. Moreover, the market is responsive to trends in digital health solutions, personalized medicine, and comprehensive management strategies, creating opportunities for companies to differentiate themselves and capture market share.

In June 2023, Pfizer Inc. relaunched DUAVEE (conjugated estrogens/bazedoxifene), an estrogen-containing menopausal hormone treatment, to the U.S. market with improved packaging. This return follows a voluntary recall sparked by a packaging issue that had nothing to do with any concerns about the product’s efficacy or safety. This relaunch technique addresses packaging difficulties while also generating revenue from sales.

In February 2023, Sandoz obtained a Biologics Licence Application (BLA) from the U.S. Food & Drug Administration (FDA) for a potential denosumab biosimilar (Prolia and Xgeva; Amgen). The medicine is meant to treat a wide range of medical disorders, including osteoporosis in postmenopausal women and males with an increased fracture risk, among others.

Summary of Key Findings

  • The global postmenopausal osteoporosis treatment market has experienced steady growth in recent years owing to factors such as an aging population, therapeutic innovations, and increased awareness of bone health.
  • The market is segmented by treatment type, administration method, drug delivery systems, patient demographics, end users, patient risk factors, market trends, and region.
  • Monoclonal antibodies are emerging as a key growth segment in terms of treatment type, showcasing a high market CAGR due to their targeted approach.
  • Oral medications are anticipated to witness a surge in demand in the administration method, owing to the growing preference for convenient and patient-friendly treatment options.
  • Postmenopausal women patient demographics currently lead the market share, showcasing the impact of hormonal changes as a key risk factor.
  • The market includes medications, biopharmaceuticals, and medical devices used to prevent fractures and maintain bone health in postmenopausal women.

Future Outlook

  • The integration of digital health solutions, including telemedicine, wearable devices, and health apps, is anticipated to play a significant role in the future of osteoporosis treatment.
  • The market is likely to witness increased activity in emerging markets, especially in the Asia Pacific region, as healthcare infrastructure continues to improve and awareness about postmenopausal osteoporosis grows.
  • A shift towards outpatient care is expected to impact the market dynamics, with clinics and physician offices registering higher growth rates.
  • Increasing awareness about bone health and the role of preventive healthcare measures is expected to propel a shift toward proactive management of postmenopausal osteoporosis.

Segmentation

  • By Treatment Type
    • Bisphosphonates
    • Hormone Replacement Therapy (HRT)
    • Selective Estrogen Receptor Modulators (SERMs)
    • Monoclonal Antibodies
    • Calcium and Vitamin D Supplements
    • Anabolic Agents
    • Non-pharmacological Therapies
  • By Administration Method
    • Oral Medications
    • Intravenous Medications
    • Subcutaneous Injections
  • By Drug Delivery Systems
    • Conventional Formulations
    • Long-Acting Formulations
  • By Patient Demographics
    • Postmenopausal Women
    • Elderly Population
  • By End Users
    • Hospitals
    • Clinics and Physician Offices
    • Home Healthcare
  • By Patient Risk Factors
    • High-Risk Patients
    • Patients with Fractures
  • By Market Trends
    • Emerging Therapies
    • Personalized Medicine
    • Focus on Bone Health
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Postmenopausal Osteoporosis Treatment Market
2.1.1. Global Postmenopausal Osteoporosis Treatment Market, By Treatment Type
2.1.2. Global Postmenopausal Osteoporosis Treatment Market, By Administration Method
2.1.3. Global Postmenopausal Osteoporosis Treatment Market, By Drug Delivery Systems
2.1.4. Global Postmenopausal Osteoporosis Treatment Market, By Patient Demographics
2.1.5. Global Postmenopausal Osteoporosis Treatment Market, By End Users
2.1.6. Global Postmenopausal Osteoporosis Treatment Market, By Patient Risk Factors
2.1.7. Global Postmenopausal Osteoporosis Treatment Market, By Market Trends
2.1.8. Global Postmenopausal Osteoporosis Treatment Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Postmenopausal Osteoporosis Treatment Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Postmenopausal Osteoporosis Treatment Market Drivers
3.2.2. Postmenopausal Osteoporosis Treatment Market Restraints
3.2.3. Postmenopausal Osteoporosis Treatment Market Opportunities
3.2.4. Major Postmenopausal Osteoporosis Treatment Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Treatment Type
3.5.2. Administration Method
3.5.3. Drug Delivery Systems
3.5.4. Patient Demographics
3.5.5. End Users
3.5.6. Patient Risk Factors
3.5.7. Market Trends
3.5.8. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Postmenopausal Osteoporosis Treatment Market: Company Market Share, Value 2022
4.1.2. Global Postmenopausal Osteoporosis Treatment Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Postmenopausal Osteoporosis Treatment Market: Top 3 Company Market Share, Value 2022
4.2. Global Postmenopausal Osteoporosis Treatment Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Postmenopausal Osteoporosis Treatment Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID-19 and Russia – Ukraine War on Postmenopausal Osteoporosis Treatment Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Postmenopausal Osteoporosis Treatment Market, By Treatment Type
8.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Treatment Type
8.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Treatment Type, 2022 Vs 2030 (in %)
8.2. Bisphosphonates
8.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Bisphosphonates, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Bisphosphonates
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Hormone Replacement Therapy (HRT)
8.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Hormone Replacement Therapy (HRT), By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Hormone Replacement Therapy (HRT)
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Selective Estrogen Receptor Modulators (SERMs)
8.4.1. Global Postmenopausal Osteoporosis Treatment Market, By Selective Estrogen Receptor Modulators (SERMs), By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Selective Estrogen Receptor Modulators (SERMs)
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Monoclonal Antibodies
8.5.1. Global Postmenopausal Osteoporosis Treatment Market, By Monoclonal Antibodies, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Monoclonal Antibodies
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Calcium and Vitamin D Supplements
8.6.1. Global Postmenopausal Osteoporosis Treatment Market, By Calcium and Vitamin D Supplements, By Region, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Calcium and Vitamin D Supplements
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
8.7. Anabolic Agents
8.7.1. Global Postmenopausal Osteoporosis Treatment Market, By Anabolic Agents, By Region, 2017-2030 (US$ Mn)
8.7.2. Market Dynamics for Anabolic Agents
8.7.2.1. Drivers
8.7.2.2. Restraints
8.7.2.3. Opportunities
8.7.2.4. Trends
8.8. Non-pharmacological Therapies
8.8.1. Global Postmenopausal Osteoporosis Treatment Market, By Non-pharmacological Therapies, By Region, 2017-2030 (US$ Mn)
8.8.2. Market Dynamics for Non-pharmacological Therapies
8.8.2.1. Drivers
8.8.2.2. Restraints
8.8.2.3. Opportunities
8.8.2.4. Trends
9. Global Postmenopausal Osteoporosis Treatment Market, By Administration Method
9.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Administration Method
9.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Administration Method, 2022 Vs 2030 (in %)
9.2. Oral Medications
9.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Oral Medications, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Oral Medications
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Intravenous Medications
9.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Intravenous Medications, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Intravenous Medications
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Subcutaneous Injections
9.4.1. Global Postmenopausal Osteoporosis Treatment Market, By Subcutaneous Injections, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Subcutaneous Injections
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
10. Global Postmenopausal Osteoporosis Treatment Market, By Drug Delivery Systems
10.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Drug Delivery Systems
10.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Drug Delivery Systems, 2022 Vs 2030 (in %)
10.2. Conventional Formulations
10.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Conventional Formulations, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Conventional Formulations
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Long-Acting Formulations
10.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Long-Acting Formulations, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Long-Acting Formulations
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Postmenopausal Osteoporosis Treatment Market, By Patient Demographics
11.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Patient Demographics
11.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Patient Demographics, 2022 Vs 2030 (in %)
11.2. Postmenopausal Women
11.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Postmenopausal Women, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Postmenopausal Women
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Elderly Population
11.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Elderly Population, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Elderly Population
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global Postmenopausal Osteoporosis Treatment Market, By End Users
12.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by End Users
12.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By End Users, 2022 Vs 2030 (in %)
12.2. Hospitals
12.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Hospitals, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Hospitals
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Clinics and Physician Offices
12.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Clinics and Physician Offices, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Clinics and Physician Offices
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Home Healthcare
12.4.1. Global Postmenopausal Osteoporosis Treatment Market, By Home Healthcare, By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Home Healthcare
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Postmenopausal Osteoporosis Treatment Market, By Patient Risk Factors
13.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Patient Risk Factors
13.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Patient Risk Factors, 2022 Vs 2030 (in %)
13.2. High-Risk Patients
13.2.1. Global Postmenopausal Osteoporosis Treatment Market, By High-Risk Patients, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for High-Risk Patients
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Patients with Fractures
13.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Patients with Fractures, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Patients with Fractures
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global Postmenopausal Osteoporosis Treatment Market, By Market Trends
14.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Market Trends
14.1.1. Global Postmenopausal Osteoporosis Treatment Market Revenue Share, By Market Trends, 2022 Vs 2030 (in %)
14.2. Emerging Therapies
14.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Emerging Therapies, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Emerging Therapies
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Personalized Medicine
14.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Personalized Medicine, By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Personalized Medicine
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
14.4. Focus on Bone Health
14.4.1. Global Postmenopausal Osteoporosis Treatment Market, By Focus on Bone Health, By Region, 2017-2030 (US$ Mn)
14.4.2. Market Dynamics for Focus on Bone Health
14.4.2.1. Drivers
14.4.2.2. Restraints
14.4.2.3. Opportunities
14.4.2.4. Trends
15. Global Postmenopausal Osteoporosis Treatment Market, By Region
15.1. Global Postmenopausal Osteoporosis Treatment Market Overview, by Region
15.1.1. Global Postmenopausal Osteoporosis Treatment Market, By Region, 2022 vs 2030 (in%)
15.2. Treatment Type
15.2.1. Global Postmenopausal Osteoporosis Treatment Market, By Treatment Type, 2017-2030 (US$ Mn)
15.3. Administration Method
15.3.1. Global Postmenopausal Osteoporosis Treatment Market, By Administration Method, 2017-2030 (US$ Mn)
15.4. Drug Delivery Systems
15.4.1. Global Postmenopausal Osteoporosis Treatment Market, By Drug Delivery Systems, 2017-2030 (US$ Mn)
15.5. Patient Demographics
15.5.1. Global Postmenopausal Osteoporosis Treatment Market, By Patient Demographics, 2017-2030 (US$ Mn)
15.6. End Users
15.6.1. Global Postmenopausal Osteoporosis Treatment Market, By End Users, 2017-2030 (US$ Mn)
15.7. Patient Risk Factors
15.7.1. Global Postmenopausal Osteoporosis Treatment Market, By Patient Risk Factors, 2017-2030 (US$ Mn)
15.8. Market Trends
15.8.1. Global Postmenopausal Osteoporosis Treatment Market, By Market Trends, 2017-2030 (US$ Mn)
16. North America Postmenopausal Osteoporosis Treatment Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. North America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. North America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. North America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. North America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. North America Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. North America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. North America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
16.8.1. Overview
16.8.2. SRC Analysis
16.9. North America Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
16.9.1. North America Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
16.9.2. U.S.
16.9.3. Canada
16.9.4. Mexico
17. Europe Postmenopausal Osteoporosis Treatment Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Europe Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Europe Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Europe Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Europe Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Europe Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Europe Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Europe Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Europe Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
17.9.1. Europe Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
17.9.2. UK
17.9.3. France
17.9.4. Germany
17.9.5. Italy
17.9.6. Spain
17.9.7. Benelux
17.9.8. Russia
17.9.9. Rest of Europe
18. Asia Pacific Postmenopausal Osteoporosis Treatment Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
18.9.1. Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
18.9.2. China
18.9.3. Japan
18.9.4. India
18.9.5. South Korea
18.9.6. South East Asia
18.9.7. Rest of Asia Pacific
19. Latin America Postmenopausal Osteoporosis Treatment Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Latin America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Latin America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Latin America Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Latin America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Latin America Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
19.9.1. Latin America Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
19.9.2. Brazil
19.9.3. Argentina
19.9.4. Rest of Latin America
20. Middle East Postmenopausal Osteoporosis Treatment Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Middle East Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Middle East Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Middle East Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Middle East Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Middle East Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Middle East Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
20.9.1. Middle East Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
20.9.2. UAE
20.9.3. Saudi Arabia
20.9.4. Rest of Middle East
21. Africa Postmenopausal Osteoporosis Treatment Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Africa Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2030 (US$ Mn)
21.9.1. Middle East Postmenopausal Osteoporosis Treatment Market, by Country, 2022 Vs 2030 (in%)
21.9.2. South Africa
21.9.3. Egypt
21.9.4. Rest of Africa
22. Company Profiles
22.1. Amgen Inc
22.1.1. Company Overview
22.1.2. Products/Services Portfolio
22.1.3. Geographical Presence
22.1.4. SWOT Analysis
22.1.5. Financial Summary
22.1.5.1. Market Revenue and Net Profit (2019-2022)
22.1.5.2. Business Segment Revenue Analysis
22.1.5.3. Geographical Revenue Analysis
22.2. Eli Lilly & Company
22.3. Novartis International AG
22.4. Gilead Sciences Inc
22.5. Teva Pharmaceutical Industries Ltd
22.6. Merck & Co. Inc
22.7. Pfizer Inc
22.8. GlaxoSmithKline Plc
22.9. Roche Holding AG
22.10. Johnson & Johnson
22.11. Sanofi S.A.
22.12. Sun Pharmaceutical Industries Ltd
22.13. Mylan N.V. (now part of Viatris Inc)
22.14. Accord Healthcare Ltd
22.15. Others
23. Research Methodology
23.1. Research Methodology
23.2. Phase I – Secondary Research
23.3. Phase II – Data Modelling
23.3.1. Company Share Analysis Model
23.3.2. Revenue Based Modelling
23.4. Phase III – Primary Research
23.5. Research Limitations
23.5.1. Assumptions

List of Figures
FIG. 1 Global Postmenopausal Osteoporosis Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Postmenopausal Osteoporosis Treatment Market Segmentation
FIG. 4 Global Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2022 (US$ Mn)
FIG. 5 Global Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2022 (US$ Mn)
FIG. 6 Global Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2022 (US$ Mn)
FIG. 7 Global Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, 2022 (US$ Mn)
FIG. 8 Global Postmenopausal Osteoporosis Treatment Market, by End Users, 2022 (US$ Mn)
FIG. 9 Global Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2022 (US$ Mn)
FIG. 10 Global Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2022 (US$ Mn)
FIG. 11 Global Postmenopausal Osteoporosis Treatment Market, by Geography, 2022 (US$ Mn)
FIG. 12 Attractive Investment Proposition, by Treatment Type, 2022
FIG. 13 Attractive Investment Proposition, by Administration Method, 2022
FIG. 14 Attractive Investment Proposition, by Drug Delivery Systems, 2022
FIG. 15 Attractive Investment Proposition, by Patient Demographics, 2022
FIG. 16 Attractive Investment Proposition, by End Users, 2022
FIG. 17 Attractive Investment Proposition, by Patient Risk Factors, 2022
FIG. 18 Attractive Investment Proposition, by Market Trends, 2022
FIG. 19 Attractive Investment Proposition, by Geography, 2022
FIG. 20 Global Market Share Analysis of Key Postmenopausal Osteoporosis Treatment Market Manufacturers, 2022
FIG. 21 Global Market Positioning of Key Postmenopausal Osteoporosis Treatment Market Manufacturers, 2022
FIG. 22 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Treatment Type, 2022 & 2030 (Value %)
FIG. 23 Global Postmenopausal Osteoporosis Treatment Market, by Bisphosphonates, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Postmenopausal Osteoporosis Treatment Market, by Hormone Replacement Therapy (HRT), Value, 2017-2030 (US$ Mn)
FIG. 25 Global Postmenopausal Osteoporosis Treatment Market, by Selective Estrogen Receptor Modulators (SERMs), Value, 2017-2030 (US$ Mn)
FIG. 26 Global Postmenopausal Osteoporosis Treatment Market, by Monoclonal Antibodies, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Postmenopausal Osteoporosis Treatment Market, by Calcium and Vitamin D Supplements, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Postmenopausal Osteoporosis Treatment Market, by Anabolic Agents, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Postmenopausal Osteoporosis Treatment Market, by Non-pharmacological Therapies, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Administration Method, 2022 & 2030 (Value %)
FIG. 31 Global Postmenopausal Osteoporosis Treatment Market, by Oral Medications, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Postmenopausal Osteoporosis Treatment Market, by Intravenous Medications, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Postmenopausal Osteoporosis Treatment Market, by Subcutaneous Injections, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Drug Delivery Systems, 2022 & 2030 (Value %)
FIG. 35 Global Postmenopausal Osteoporosis Treatment Market, by Conventional Formulations, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Postmenopausal Osteoporosis Treatment Market, by Long-Acting Formulations, Value, 2017-2030 (US$ Mn)
FIG. 37 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Patient Demographics, 2022 & 2030 (Value %)
FIG. 38 Global Postmenopausal Osteoporosis Treatment Market, by Postmenopausal Women, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Postmenopausal Osteoporosis Treatment Market, by Elderly Population, Value, 2017-2030 (US$ Mn)
FIG. 40 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By End Users, 2022 & 2030 (Value %)
FIG. 41 Global Postmenopausal Osteoporosis Treatment Market, by Hospitals, Value, 2017-2030 (US$ Mn)
FIG. 42 Global Postmenopausal Osteoporosis Treatment Market, by Clinics and Physician Offices, Value, 2017-2030 (US$ Mn)
FIG. 43 Global Postmenopausal Osteoporosis Treatment Market, by Home Healthcare, Value, 2017-2030 (US$ Mn)
FIG. 44 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Patient Risk Factors, 2022 & 2030 (Value %)
FIG. 45 Global Postmenopausal Osteoporosis Treatment Market, by High-Risk Patients, Value, 2017-2030 (US$ Mn)
FIG. 46 Global Postmenopausal Osteoporosis Treatment Market, by Patients with Fractures, Value, 2017-2030 (US$ Mn)
FIG. 47 Global Postmenopausal Osteoporosis Treatment Market Value Contribution, By Market Trends, 2022 & 2030 (Value %)
FIG. 48 Global Postmenopausal Osteoporosis Treatment Market, by Emerging Therapies, Value, 2017-2030 (US$ Mn)
FIG. 49 Global Postmenopausal Osteoporosis Treatment Market, by Personalized Medicine, Value, 2017-2030 (US$ Mn)
FIG. 50 North America Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 51 U.S. Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 52 Canada Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 53 Mexico Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 54 Europe Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 55 Germany Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 56 France Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 57 U.K. Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 58 Italy Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 59 Spain Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 60 Benelux Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 61 Russia Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 62 Rest of Europe Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 63 Asia Pacific Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 64 China Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 65 Japan Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 66 India Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 67 South Korea Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 68 South-East Asia Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 69 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 70 Latin America Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 71 Brazil Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 72 Argentina Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 73 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 74 Middle East Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 75 UAE Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 76 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 77 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 78 Africa Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 79 South Africa Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 80 Egypt Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)
FIG. 81 Rest of Africa Postmenopausal Osteoporosis Treatment Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Postmenopausal Osteoporosis Treatment Market
TABLE 2 Global Postmenopausal Osteoporosis Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Postmenopausal Osteoporosis Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Postmenopausal Osteoporosis Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Postmenopausal Osteoporosis Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Postmenopausal Osteoporosis Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Postmenopausal Osteoporosis Treatment Market, by Bisphosphonates, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Postmenopausal Osteoporosis Treatment Market, by Bisphosphonates, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Postmenopausal Osteoporosis Treatment Market, by Hormone Replacement Therapy (HRT), By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Postmenopausal Osteoporosis Treatment Market, by Hormone Replacement Therapy (HRT), By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Postmenopausal Osteoporosis Treatment Market, by Selective Estrogen Receptor Modulators (SERMs), By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Postmenopausal Osteoporosis Treatment Market, by Selective Estrogen Receptor Modulators (SERMs), By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Postmenopausal Osteoporosis Treatment Market, by Monoclonal Antibodies, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Postmenopausal Osteoporosis Treatment Market, by Monoclonal Antibodies, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Postmenopausal Osteoporosis Treatment Market, by Calcium and Vitamin D Supplements, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Postmenopausal Osteoporosis Treatment Market, by Calcium and Vitamin D Supplements, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Postmenopausal Osteoporosis Treatment Market, by Anabolic Agents, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Postmenopausal Osteoporosis Treatment Market, by Anabolic Agents, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Postmenopausal Osteoporosis Treatment Market, by Non-pharmacological Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Postmenopausal Osteoporosis Treatment Market, by Non-pharmacological Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Postmenopausal Osteoporosis Treatment Market, by Oral Medications, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Postmenopausal Osteoporosis Treatment Market, by Oral Medications, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Postmenopausal Osteoporosis Treatment Market, by Intravenous Medications, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Postmenopausal Osteoporosis Treatment Market, by Intravenous Medications, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Postmenopausal Osteoporosis Treatment Market, by Subcutaneous Injections, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Postmenopausal Osteoporosis Treatment Market, by Subcutaneous Injections, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Postmenopausal Osteoporosis Treatment Market, by Conventional Formulations, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Postmenopausal Osteoporosis Treatment Market, by Conventional Formulations, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Postmenopausal Osteoporosis Treatment Market, by Long-Acting Formulations, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Postmenopausal Osteoporosis Treatment Market, by Long-Acting Formulations, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Postmenopausal Osteoporosis Treatment Market, by Postmenopausal Women, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Postmenopausal Osteoporosis Treatment Market, by Postmenopausal Women, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Postmenopausal Osteoporosis Treatment Market, by Elderly Population, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Postmenopausal Osteoporosis Treatment Market, by Elderly Population, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Postmenopausal Osteoporosis Treatment Market, by Hospitals, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Postmenopausal Osteoporosis Treatment Market, by Hospitals, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Postmenopausal Osteoporosis Treatment Market, by Clinics and Physician Offices, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Postmenopausal Osteoporosis Treatment Market, by Clinics and Physician Offices, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Postmenopausal Osteoporosis Treatment Market, by Home Healthcare, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Postmenopausal Osteoporosis Treatment Market, by Home Healthcare, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Postmenopausal Osteoporosis Treatment Market, by High-Risk Patients, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Postmenopausal Osteoporosis Treatment Market, by High-Risk Patients, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Postmenopausal Osteoporosis Treatment Market, by Patients with Fractures, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Postmenopausal Osteoporosis Treatment Market, by Patients with Fractures, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Postmenopausal Osteoporosis Treatment Market, by Emerging Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global Postmenopausal Osteoporosis Treatment Market, by Emerging Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global Postmenopausal Osteoporosis Treatment Market, by Personalized Medicine, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global Postmenopausal Osteoporosis Treatment Market, by Personalized Medicine, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 50 Global Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 51 Global Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 52 Global Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 53 Global Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 54 Global Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 55 Global Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 56 Global Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 57 Global Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 58 Global Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 59 Global Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 60 Global Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 61 Global Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 62 Global Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 63 Global Postmenopausal Osteoporosis Treatment Market, by Region, 2017-2022 (US$ Mn)
TABLE 64 Global Postmenopausal Osteoporosis Treatment Market, by Region, 2023-2030 (US$ Mn)
TABLE 65 North America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 66 North America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 67 North America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 68 North America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 69 North America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 70 North America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 71 North America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 72 North America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 73 North America Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 74 North America Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 75 North America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 76 North America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 77 North America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 78 North America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 79 North America Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2022 (US$ Mn)
TABLE 80 North America Postmenopausal Osteoporosis Treatment Market, by Country, 2023-2030 (US$ Mn)
TABLE 81 United States Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 82 United States Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 83 United States Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 84 United States Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 85 United States Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 86 United States Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 87 United States Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 88 United States Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 89 United States Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 90 United States Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 91 United States Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 92 United States Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 93 United States Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 94 United States Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 95 Canada Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 96 Canada Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 97 Canada Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 98 Canada Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 99 Canada Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 100 Canada Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 101 Canada Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 102 Canada Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 103 Canada Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 104 Canada Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 105 Canada Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 106 Canada Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 107 Canada Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 108 Canada Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 109 Mexico Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 110 Mexico Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 111 Mexico Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 112 Mexico Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 113 Mexico Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 114 Mexico Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 115 Mexico Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 116 Mexico Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 117 Mexico Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 118 Mexico Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 119 Mexico Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 120 Mexico Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 121 Mexico Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 122 Mexico Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 123 Europe Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 124 Europe Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 125 Europe Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 126 Europe Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 127 Europe Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 128 Europe Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 129 Europe Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 130 Europe Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 131 Europe Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 132 Europe Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 133 Europe Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 134 Europe Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 135 Europe Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 136 Europe Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 137 Europe Postmenopausal Osteoporosis Treatment Market, by Country, 2017-2022 (US$ Mn)
TABLE 138 Europe Postmenopausal Osteoporosis Treatment Market, by Country, 2023-2030 (US$ Mn)
TABLE 139 Germany Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 140 Germany Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 141 Germany Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 142 Germany Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 143 Germany Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 144 Germany Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 145 Germany Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 146 Germany Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 147 Germany Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 148 Germany Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 149 Germany Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 150 Germany Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 151 Germany Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 152 Germany Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 153 France Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 154 France Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 155 France Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 156 France Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 157 France Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 158 France Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 159 France Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 160 France Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 161 France Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 162 France Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 163 France Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 164 France Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 165 France Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 166 France Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 167 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 168 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 169 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 170 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 171 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 172 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 173 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 174 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 175 United Kingdom Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 176 United Kingdom Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 177 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 178 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 179 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 180 United Kingdom Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 181 Italy Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 182 Italy Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 183 Italy Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 184 Italy Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 185 Italy Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 186 Italy Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 187 Italy Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 188 Italy Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 189 Italy Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 190 Italy Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 191 Italy Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 192 Italy Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 193 Italy Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 194 Italy Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 195 Spain Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 196 Spain Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 197 Spain Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 198 Spain Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 199 Spain Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 200 Spain Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 201 Spain Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 202 Spain Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 203 Spain Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 204 Spain Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 205 Spain Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 206 Spain Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 207 Spain Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 208 Spain Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 209 Benelux Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 210 Benelux Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 211 Benelux Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 212 Benelux Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 213 Benelux Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 214 Benelux Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 215 Benelux Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 216 Benelux Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 217 Benelux Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 218 Benelux Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 219 Benelux Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 220 Benelux Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 221 Benelux Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 222 Benelux Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 223 Russia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 224 Russia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 225 Russia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 226 Russia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 227 Russia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 228 Russia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 229 Russia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 230 Russia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 231 Russia Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 232 Russia Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 233 Russia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 234 Russia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 235 Russia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 236 Russia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 237 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 238 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 239 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 240 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 241 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 242 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 243 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 244 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 245 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 246 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 247 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 248 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 249 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 250 Rest of Europe Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 251 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 252 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 253 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 254 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 255 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 256 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 257 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 258 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 259 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 260 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 261 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 262 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 263 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 264 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 265 China Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 266 China Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 267 China Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 268 China Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 269 China Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 270 China Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 271 China Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 272 China Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 273 China Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 274 China Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 275 China Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 276 China Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 277 China Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 278 China Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 279 Japan Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 280 Japan Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 281 Japan Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 282 Japan Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 283 Japan Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 284 Japan Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 285 Japan Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 286 Japan Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 287 Japan Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 288 Japan Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 289 Japan Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 290 Japan Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 291 Japan Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 292 Japan Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 293 India Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 294 India Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 295 India Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 296 India Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 297 India Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 298 India Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 299 India Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 300 India Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 301 India Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 302 India Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 303 India Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 304 India Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 305 India Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 306 India Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 307 South Korea Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 308 South Korea Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 309 South Korea Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 310 South Korea Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 311 South Korea Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 312 South Korea Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 313 South Korea Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 314 South Korea Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 315 South Korea Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 316 South Korea Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 317 South Korea Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 318 South Korea Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 319 South Korea Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 320 South Korea Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 321 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 322 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 323 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 324 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 325 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 326 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 327 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 328 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 329 South-East Asia Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 330 South-East Asia Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 331 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 332 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 333 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 334 South-East Asia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 335 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 336 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 337 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 338 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 339 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 340 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 341 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 342 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 343 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 344 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 345 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 346 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 347 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 348 Rest of Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 349 Latin America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 350 Latin America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 351 Latin America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 352 Latin America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 353 Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 354 Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 355 Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 356 Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 357 Latin America Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 358 Latin America Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 359 Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 360 Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 361 Latin America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 362 Latin America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 363 Brazil Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 364 Brazil Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 365 Brazil Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 366 Brazil Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 367 Brazil Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 368 Brazil Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 369 Brazil Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 370 Brazil Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 371 Brazil Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 372 Brazil Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 373 Brazil Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 374 Brazil Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 375 Brazil Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 376 Brazil Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 377 Argentina Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 378 Argentina Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 379 Argentina Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 380 Argentina Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 381 Argentina Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 382 Argentina Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 383 Argentina Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 384 Argentina Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 385 Argentina Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 386 Argentina Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 387 Argentina Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 388 Argentina Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 389 Argentina Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 390 Argentina Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 391 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 392 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 393 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 394 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 395 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 396 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 397 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 398 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 399 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 400 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 401 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 402 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 403 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 404 Rest of Latin America Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 405 Middle East Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 406 Middle East Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 407 Middle East Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 408 Middle East Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 409 Middle East Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 410 Middle East Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 411 Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 412 Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 413 Middle East Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 414 Middle East Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 415 Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 416 Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 417 Middle East Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 418 Middle East Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 419 UAE Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 420 UAE Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 421 UAE Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 422 UAE Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 423 UAE Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 424 UAE Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 425 UAE Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 426 UAE Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 427 UAE Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 428 UAE Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 429 UAE Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 430 UAE Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 431 UAE Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 432 UAE Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 433 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 434 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 435 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 436 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 437 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 438 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 439 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 440 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 441 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 442 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 443 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 444 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 445 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 446 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 447 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 448 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 449 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 450 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 451 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 452 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 453 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 454 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 455 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 456 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 457 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 458 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 459 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 460 Rest of Middle East Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 461 Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 462 Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 463 Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 464 Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 465 Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 466 Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 467 Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 468 Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 469 Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 470 Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 471 Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 472 Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 473 Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 474 Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 475 South Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 476 South Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 477 South Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 478 South Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 479 South Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 480 South Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 481 South Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 482 South Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 483 South Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 484 South Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 485 South Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 486 South Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 487 South Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 488 South Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 489 Egypt Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 490 Egypt Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 491 Egypt Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 492 Egypt Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 493 Egypt Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 494 Egypt Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 495 Egypt Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 496 Egypt Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 497 Egypt Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 498 Egypt Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 499 Egypt Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 500 Egypt Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 501 Egypt Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 502 Egypt Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)
TABLE 503 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2017-2022 (US$ Mn)
TABLE 504 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Treatment Type, 2023-2030 (US$ Mn)
TABLE 505 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2017-2022 (US$ Mn)
TABLE 506 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Administration Method, 2023-2030 (US$ Mn)
TABLE 507 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2017-2022 (US$ Mn)
TABLE 508 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Drug Delivery Systems, 2023-2030 (US$ Mn)
TABLE 509 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2017-2022 (US$ Mn)
TABLE 510 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Patient Demographics, By Region, 2023-2030 (US$ Mn)
TABLE 511 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2017-2022 (US$ Mn)
TABLE 512 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by End Users, 2023-2030 (US$ Mn)
TABLE 513 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2017-2022 (US$ Mn)
TABLE 514 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Patient Risk Factors, 2023-2030 (US$ Mn)
TABLE 515 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2017-2022 (US$ Mn)
TABLE 516 Rest of Africa Postmenopausal Osteoporosis Treatment Market, by Market Trends, 2023-2030 (US$ Mn)

What is the current size of the global postmenopausal osteoporosis treatment market?

The global postmenopausal osteoporosis treatment market was valued at USD 9514.5 Million in 2022.

What is the expected growth rate of the postmenopausal osteoporosis treatment market between 2023 and 2030?

The postmenopausal osteoporosis treatment market is predicted to grow at a CAGR of 5.5% between 2023 and 2030, reaching USD 14601.8 Million in 2030.

Which segment is leading the market share in terms of treatment type?

Bisphosphonates are the leading treatment type segment, holding over 20% share in value in 2022.

Which administration method segment governs the global demand for postmenopausal osteoporosis treatment?

The intravenous medications segment governs the global demand for postmenopausal osteoporosis treatment, holding a massive share of over 38% in 2022.

Which patient demographics segment will post the highest CAGR in the forecast period?

The elderly patient population segment will post the highest CAGR over the projection period.

Nanoparticle Formulation Market

Published:
Report ID: 41106

Animal Drug Compounding Market

Published:
Report ID: 40870

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

Intravitreal Injectable Market

Published:
Report ID: 7250

Pharmacogenomics Market

Published:
Report ID: 9486

Nosocomial Infection Treatment Market

Published:
Report ID: 14189

Anti-Cancer Drugs Market

Published:
Report ID: 39971

Vial Adaptors for Reconstitution Drug Market

Published:
Report ID: 15561

Congenital Disabilities Market

Published:
Report ID: 39845

Acquired Hemophilia Treatment Market

Published:
Report ID: 1124

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN